期刊文献+

常规透析浓缩液条件下血液透析局部枸橼酸抗凝研究 被引量:5

Study on the Anticogulation of Regional Citrate in Hemodialysis Under Conventional Dialysis Concentrated Solution
暂未订购
导出
摘要 【目的】研究局部枸橼酸抗凝(RCA)在常规透析浓缩液条件下利用透析机的“可调钠”功能在血液透析中的应用,以期摸索出一套操作简便切实可行的RCA方法。【方法】选择30例患者分为两组:局部枸橼酸抗凝组(RCA组)15例,行血液净化30例次;对照组(肝素组)15例,行小剂量肝素血液净化30例次。监测全血活化凝血时间(ACT);观察体外循环凝血情况如滤器血管路凝血情况及患者临床出血情况;监测血清pH值、游离钙(iCa^2+)、血钠离子(Na^+)、碳酸氢根(HCO3^-)浓度;监测血尿素(Urea)、血清肌酐(SCr)并计算尿素清除率(URR)等。【结果】①透析2h、4h时滤器前采血与透前比较:RCA组ACT无明显变化(P〉0.05),而肝素组ACT明显延长(P〈O.05);滤器后采血与透前比较:两组透后ACT均延长(P〈0.05);②透析2h、4h时滤器后采血与透前比较:RCA组iCa浓度降低(P〈0.01),其与ACT值呈高度负相关(r=0.79、r=0.83),肝素组iCa^2+浓度无明显变化;③透析后两组pH、HCO3^-、血钠均在正常范围;透析4h两组SCr下降率分别为57.83%、58.61%,URR为67.52%、69.23%。【结论】改良后的常规透析浓缩液条件下局部RCA抗凝操作简便且体外抗凝效果肯定、安全,不影响治疗效率;iCa^2+可替代ACT作为凝血监测指标。 [Objective] To investigate the application of regional citrate anticoagulation(RCA) under conventional dialysis concentrated solution in adjustable sodium hemodialysis in order to explore a simple and feasible method of RCA. [Methods] Thirty patients were divided into RCA group( n =15) and heparin group( n = 15). Thirty cases in RCA group underwent blood purification. Thirty cases in heparin group underwent blood purification with low doses of heparin. The activated coagulation time(ACT) in whole blood was monitored. The coagulation in extracorporeal circulation such as the coagulation of filter vessel channel and the clinical bleeding of the patients were observed. Serum pH, free calcium(iCa24 ), serum sodium(Na^+ ) and bicarbonate (HCO3^- ) concentration were observed. Blood urea(Urea) and serum creatinine('SCr) were monitored, and urea clearance rate(URR) was calculated. [Results] When blood collection before filtration at 2h and 4h of dialysis was compared with that before dialysis, there was no obvious change of ACT in RCA group( P 〉0.05), but the ACT in heparin group was significantly prolonged( P 〈0.05). When blood collection after filtration was compared with that before dialysis, the ACT in both groups were prolonged( P 〈0.05). When blood collection after filtration at 2h and 4h of dialysis was compared with before dialysis, the iCa^+ concentration in RCA decreased( P 〈0.01) and was negatively correlated with ACT(r=0.79, r=0.83), but iCa in heparin group showed no obvious change. After dialysis, the pH, HCO3^- and Na^+ in both groups were within the normal range. The rate of the decrease of SCr in both groups at 4h of dialysis was 57.83% and 58.61%, respectively. The URR in both groups was 67.52% and 69.23%, respectively. [Conclusion] RCA under modifled conventional dialysis concentrated solution is simple to operate, and its anticoagulation effect is certain and safe. it does not affect the therapeutic efficacy. The iCa ^+ can substitute for ACT to be the coagulation monitoring indicator,
出处 《医学临床研究》 CAS 2011年第1期50-52,共3页 Journal of Clinical Research
关键词 血液透析 柠檬酸盐类 hemodialysis citrates
  • 相关文献

参考文献6

二级参考文献27

  • 1陈舜杰,叶朝阳,张玉强,陈静,马晓红,张斌,梅长林.枸橼酸钠置换液在连续性肾脏替代治疗中的应用[J].中国血液净化,2005,4(1):42-44. 被引量:6
  • 2戎殳,叶朝阳,孙丽君,陈静,张斌,梅长林.46.7%枸橼酸钠溶液在血液透析患者长期留置导管封管的应用[J].中华肾脏病杂志,2007,23(2):110-112. 被引量:29
  • 3Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofihration in critically ill patients with a high risk of bleeding. Kidney Int, 1999,55 : 1 991.
  • 4Azra Bihorac, MD, and Edward A. Ross, MD. Continuous Venovenous Hemofihration With Citrate Based Replacement Fluid : Efficacy, Safety,and Impact On Nutrition. American Journal of Kidney Diseases, 2005, 46(5) :908-918.
  • 5Jamshid A, Robert FR. Anticoagulation and Continuous Renal Replace- ment Therapy. Seminars in Dialysis,2006,19(4) :311-316.
  • 6Weijmer MC, Debets Ossenkopp YJ, van de Vondervoort FJ, et al. Superior antimicrohial activity of trisodium citrate over heparin for catheter locking. Nephrol Dial Transplant,2002,17:2189- 2195.
  • 7徐友平,姚国乾.临时性血管通路建立.见:孙世澜,姚国乾,主编.血液净化理论与实践.北京:人民军医出版社,2008.61-67.
  • 8Weijmer MC,van den Dorpel MA, van de Ven PJ,et al. Randomized,clinical trial comparison of trisodium citrate 30% and heparin as cathete-locking solution in hemodialysis patients. J Am Soc Nephrol, 2005,16 : 2769-2777.
  • 9Grudzinski L, Quinan P, Kwok S, et al. Sodium citrate 40/00 locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant, 2007,22:471 476.
  • 10Meeus G, Kuypers DR, Claes K, et al. A prospective, randomized,double blind crossover study on the use of 5% citrate lock versus 10% citrate lock in permanent hemodialysis catheters. Blood Purif, 2005,23 : 101-105.

共引文献14

同被引文献32

引证文献5

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部